Cargando…
Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach
[Image: see text] Aim/Hypothesis: The complexity and heterogeneity of multiple pathological features make Alzheimer’s disease (AD) a major culprit to global health. Drug repurposing is an inexpensive and reliable approach to redirect the existing drugs for new indications. The current study aims to...
Autores principales: | Advani, Dia, Kumar, Pravir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173619/ https://www.ncbi.nlm.nih.gov/pubmed/34095679 http://dx.doi.org/10.1021/acsomega.1c01526 |
Ejemplares similares
-
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021) -
CREB1(K292) and HINFP(K330) as Putative
Common Therapeutic Targets in Alzheimer’s and Parkinson’s
Disease
por: Gupta, Rohan, et al.
Publicado: (2021) -
Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate
por: Wu, Alexander T. H., et al.
Publicado: (2021) -
Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches
por: Singh, Rakesh K.
Publicado: (2020) -
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)